Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy and Antiviral Therapy for EBV-Associated Lymphoma
NCT01964755Phase 2Terminated
- Sponsor
- University of Miami
- Start
- Apr 2009
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zidovudine in Epstein-Barr virus-associated lymphoma, Post-transplant lymphoproliferative disease (PTLD), sponsored by University of Miami. Started Apr 2009; status: terminated.
02
Drugs
zidovudine
03
Conditions
Epstein-Barr virus-associated lymphomaPost-transplant lymphoproliferative disease (PTLD)
Beyond the preview
Go deeper on NCT01964755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01964755.